Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (11)

2023

  1. Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 8, pp. 2486-2500

2022

  1. The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 2, pp. 126-135

2021

  1. A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment

    Clinical and Translational Oncology, Vol. 23, Núm. 3, pp. 434-449

  2. Immunotherapy, cancer and PET

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 2, pp. 123-135

2020

  1. FDG PET/CT in colorectal cancer

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 1, pp. 57-66

2019

  1. Image quality evaluation in a modern PET system: impact of new reconstructions methods and a radiomics approach

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors

    Clinical and Translational Oncology, Vol. 20, Núm. 12, pp. 1522-1528

  2. Phantom, clinical, and texture indices evaluation and optimization of a penalized-likelihood image reconstruction method (Q.Clear) on a BGO PET/CT scanner

    Medical Physics, Vol. 45, Núm. 7, pp. 3214-3222

  3. Radium-223 in the treatment of bone metastasis in patients with castration-resistant prostate cancer. Review and procedure

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 5, pp. 330-337

2017

  1. Performance characteristics of the whole-body discovery IQ PET/CT system

    Journal of Nuclear Medicine, Vol. 58, Núm. 7, pp. 1155-1161

2014

  1. Medicina nuclear en España: Alta tecnología 2013

    Revista Espanola de Medicina Nuclear e Imagen Molecular